ARQT Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.

$31.34  +0.65 (2.10%)
As of 03/05/2021 15:59:41 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
01/31/2020
50,084,677
263,802
$1,565,146,156
0.00%
SEC Edgar Online
10-Q
10-K
03969K108
US03969K1088
BKX9VD3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
5.78
0.00
-50.14%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy